Feasibility and effectiveness of second-line chemotherapy with mitomycin C in patients with advanced penile cancer

Desiree Louise Draeger, Oliver W. Hakenberg

Open source

DOI
10.3389/fruro.2023.1198980
Published
2024-01-24
Container
Frontiers in Urology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fruro.2023.1198980,
  title = {Feasibility and effectiveness of second-line chemotherapy with mitomycin C in patients with advanced penile cancer},
  author = {Desiree Louise Draeger and Oliver W. Hakenberg},
  year = {2024},
  journal = {Frontiers in Urology},
  doi = {10.3389/fruro.2023.1198980},
  url = {https://doi.org/10.3389/fruro.2023.1198980}
}

RIS

TY  - JOUR
TI  - Feasibility and effectiveness of second-line chemotherapy with mitomycin C in patients with advanced penile cancer
AU  - Desiree Louise Draeger
AU  - Oliver W. Hakenberg
PY  - 2024
JO  - Frontiers in Urology
DO  - 10.3389/fruro.2023.1198980
UR  - https://doi.org/10.3389/fruro.2023.1198980
ER  - 

APA

Draeger, D. L., & Hakenberg, O. W. (2024). Feasibility and effectiveness of second-line chemotherapy with mitomycin C in patients with advanced penile cancer. Frontiers in Urology. https://doi.org/10.3389/fruro.2023.1198980

Source records